Molbio Diagnostics Ltd
NSE: MOLBIO | BSE: 544866
₹1,313.20
As on 23-Sep-2026IST
Market cap
₹15,101 Cr
Revenue (TTM)
₹1,446 Cr
P/E Ratio
90.6
P/B Ratio
10.6
Div. Yield
0 %
Quality Score
5/10
Growth Score
8/10
Valuation Score
5/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹164 Cr
-
ROE
15.4 %
-
ROCE
19.8 %
-
Industry P/E
66.38
-
EV/EBITDA
45.8
-
Debt to Equity
0.4
-
Book Value
₹103.7
-
EPS
₹14.8
-
Face value
1
-
Shares outstanding
115,239,996
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Molbio Diagnostics
| -- | 19.6 | -- | -- | -- | -- | -- |
|
BSE Healthcare
| 20.1 | 3.2 | 8.1 | 16.5 | 23.4 | 14.6 | 12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Molbio Diagnostics
|
1,313.2 | 15,101.1 | 1,445.7 | 164.1 | -- | 15.4 | 90.6 | 10.6 |
| 1,924.3 | 32,270.6 | 2,890.8 | 546.3 | 23.0 | 23 | 59.6 | 12.4 | |
| 1,496.1 | 40,208.9 | 4,683.4 | 552.3 | 15.6 | 14.9 | 72.3 | 9.8 | |
| 798.1 | 33,529.1 | 4,212.5 | 190.8 | 11.9 | 9.4 | 164.1 | 8.9 | |
| 560.1 | 1,815.3 | 815.3 | 97.5 | 14.9 | 10.2 | 18.6 | 1.8 | |
| 585.5 | 12,152.7 | 1,710.0 | 202.8 | 16.8 | 14.1 | 60.3 | 7.8 | |
| 741.9 | 7,472.5 | 998.9 | 76.8 | -- | 9.2 | 97.2 | 6.6 | |
| 355.4 | 1,838.7 | 325.5 | 35.1 | 18.1 | 15.1 | 51.4 | 7.2 | |
| 573.8 | 9,132.1 | 876.0 | 174.0 | 25.3 | 32.4 | 51.8 | 14.5 | |
| 1,570.7 | 16,148.5 | 857.1 | 187.5 | 31.0 | 20.6 | 86.1 | 16.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Molbio Diagnostics
--
-
Incorporated
2000
-
Chairman
--
-
Managing Director
--
-
Headquarters
South Goa, Goa
-
Website
Looking for more details about Molbio Diagnostics Ltd’s IPO? Explore our IPO Details page.
FAQs for Molbio Diagnostics
What is the current share price of Molbio Diagnostics Ltd Today?
The share price of Molbio Diagnostics Ltd is ₹1,313.20 (NSE) and ₹1,310.40 (BSE) as of 23-Sep-2026 IST. Molbio Diagnostics Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Molbio Diagnostics Ltd?
The P/E ratio of Molbio Diagnostics Ltd is 90.65 times as on 23-Sep-2026, a 37 premium to its peers’ median range of 66.38 times.
The P/B ratio of Molbio Diagnostics Ltd is 10.62 times as on 23-Sep-2026, a 15 premium to its peers’ median range of 9.25 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
0.00 |
0.00 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2026 |
0.00 |
0.00 |
What is the 52 Week High and Low of Molbio Diagnostics Ltd?
The 52-week high and low of Molbio Diagnostics Ltd are Rs 1,686.80 and Rs 926.35 as of 23-Sep-2026.
What is the market cap of Molbio Diagnostics Ltd?
Molbio Diagnostics Ltd has a market capitalisation of ₹ 15,101 Cr as on 23-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Molbio Diagnostics Ltd?
Before investing in Molbio Diagnostics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.